Cuts Continue as Novo Nordisk Restructuring Moves Forward
Novo Nordisk is cutting 9,000 jobs globally as part of a restructuring plan.
About 5,000 positions will be reduced in Denmark.
The restructuring aims to focus on diabetes and obesity treatment areas.
Expected annual savings are $1.25 billion by 2026.
Restructuring costs of around $1.4 billion will be incurred in Q3 2025.
The company is revising its 2025 operating profit growth outlook to 4-10%.